Transfusion Requirements in Allogeneic Hematopoietic Cell Transplantation (HCT) Recipients Given Either Myeloablative or Nonmyeloablative Conditioning, and Effect of ABO Incompatibility on HCT Outcomes

被引：0
|
作者：
Wang, Zejing
Sorror, Mohamed L. [1 ]
Leisenring, Wendy [1 ]
Schoch, Gary
Malonely, David G. [1 ]
Sandmaier, Brenda M. [1 ]
Storb, Rainer F. [1 ]
机构：
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1122 / 1122
页数：1
相关论文
共 50 条
  • [1] Allogeneic hematopoietic cell transplantation (HCT) with nonmyeloablative conditioning after failed myeloablative HCT: Factors affecting outcomes.
    Baron, F
    Storb, R
    Storer, B
    Maloney, D
    Maris, M
    Niederwieser, D
    Shizuru, J
    Chauncey, T
    Bruno, B
    Forman, S
    McSweeney, P
    Maziarz, R
    Pulsipher, M
    Agura, E
    Sorror, M
    Wade, J
    Sandmaier, B
    BLOOD, 2005, 106 (11) : 333A - 333A
  • [2] THE IMPACT OF DONOR TYPE AND ABO INCOMPATIBILITY ON TRANSFUSION REQUIREMENTS AFTER NONMYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
    Wang, Z.
    Sorror, M. L.
    Leisenring, W.
    Schoch, G.
    Maloney, D.
    Sandmaier, B. M.
    Storb, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S261 - S262
  • [3] ABO incompatibility has no effect on the outcome of allogeneic hematopoietic cell transplantation (allo-HCT)
    Sakellari, I
    Stavroylanni, N
    Kalogiannidis, P
    Marantidou, M
    Ganidou, M
    Natse, T
    Batsis, I
    Anagnostopoulos, A
    Fassas, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S115 - S115
  • [4] Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning for Patients (pts) Aged ≥60 Years
    Sorror, Mohamed L.
    Storer, Barry
    Sandmaier, Brenda M.
    Maloney, David G.
    Franke, Georg
    Shizuru, Judith
    Chauncey, Thomas
    Agura, Edward
    Maziarz, Richard T.
    Sahebi, Firoozeh
    Langston, Amelia A.
    Wade, James C.
    Maris, Michael
    Bruno, Benedetto
    Yeager, Andrew M.
    Pulsipher, Michael
    Petersen, Finn
    Bethge, Wolfgang A.
    McSweeney, Peter A.
    Niederwieser, Dietger
    Blume, Karl G.
    Storb, Rainer F.
    BLOOD, 2008, 112 (11) : 753 - 754
  • [5] Allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning for relapsed or refractory follicular lymphoma.
    Maris, MB
    Sandmaier, BM
    Storer, B
    Agora, E
    Wade, J
    Maziarz, RT
    Forman, S
    Shizuru, J
    Chauncey, T
    Kahl, C
    Langston, AA
    Niederwieser, D
    Storb, R
    Maloney, DG
    BLOOD, 2005, 106 (11) : 329A - 329A
  • [6] Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation
    Baron, Frederic
    Storb, Rainer
    Storer, Barry E.
    Maris, Michael B.
    Niederwieser, Dietger
    Shizuru, Judith A.
    Chauncey, Thomas R.
    Bruno, Benedetto
    Forman, Stephen J.
    McSweeney, Peter A.
    Maziarz, Richard T.
    Pulsipher, Michael A.
    Agura, Edward D.
    Wade, James
    Sorror, Mohamed
    Maloney, David G.
    Sandmaier, Brenda M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) : 4150 - 4157
  • [7] Dialysis is an independent predictor of death in allogeneic myeloablative hematopoietic cell transplantation (HCT).
    Parikh, CR
    McSweeney, P
    Mosca, C
    Schrier, RW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 634A - 634A
  • [8] Transfusion Support of Pediatric Sickle Cell Disease (SCD) Patients Undergoing Either Reduced Intensity Conditioning (RIC) or Myeloablative Hematopoietic Cell Transplantation (HCT)
    Wong, E.
    Collier, I.
    Tekle, M.
    Criss, V.
    Pary, P.
    Fasano, R. M.
    Paul, W.
    Sande, J.
    Kamani, N.
    Luban, N. L.
    TRANSFUSION, 2011, 51 : 18A - 19A
  • [9] Comorbidities and Resource Utilization in Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
    DeCook, Lori
    Chang, Yu-Hui
    Leis, Jose
    Noel, Pierre
    Palmer, Jeanne
    Slack, James L.
    Sproat, Lisa Z.
    Sorror, Mohamed L.
    Khera, Nandita
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S86 - S87
  • [10] Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation
    Tomblyn, Marcie
    Brunstein, Claudio
    Burns, Linda J.
    Miller, Jeffrey S.
    MacMillan, Margaret
    Defor, Todd E.
    Weisdoif, Daniell J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (05) : 538 - 545
12345